Trade Relay Therapeutics, Inc. - RLAY CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.07 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023318% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001096% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 3.07 |
| Open | 2.98 |
| 1-Year Change | -49.23% |
| Day's Range | 2.98 - 3.17 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 24, 2025 | 3.15 | 0.15 | 5.00% | 3.00 | 3.18 | 2.97 |
| Apr 23, 2025 | 3.07 | 0.16 | 5.50% | 2.91 | 3.16 | 2.91 |
| Apr 22, 2025 | 2.90 | 0.14 | 5.07% | 2.76 | 2.91 | 2.69 |
| Apr 21, 2025 | 2.72 | 0.21 | 8.37% | 2.51 | 2.76 | 2.48 |
| Apr 17, 2025 | 2.66 | 0.14 | 5.56% | 2.52 | 2.67 | 2.49 |
| Apr 16, 2025 | 2.58 | -0.03 | -1.15% | 2.61 | 2.68 | 2.51 |
| Apr 15, 2025 | 2.72 | 0.32 | 13.33% | 2.40 | 2.78 | 2.40 |
| Apr 14, 2025 | 2.54 | 0.11 | 4.53% | 2.43 | 2.57 | 2.27 |
| Apr 11, 2025 | 2.39 | 0.22 | 10.14% | 2.17 | 2.39 | 2.13 |
| Apr 10, 2025 | 2.20 | 0.04 | 1.85% | 2.16 | 2.27 | 2.03 |
| Apr 9, 2025 | 2.24 | 0.37 | 19.79% | 1.87 | 2.34 | 1.79 |
| Apr 8, 2025 | 1.97 | -0.08 | -3.90% | 2.05 | 2.11 | 1.90 |
| Apr 7, 2025 | 2.02 | 0.18 | 9.78% | 1.84 | 2.04 | 1.74 |
| Apr 4, 2025 | 1.92 | -0.22 | -10.28% | 2.14 | 2.19 | 1.90 |
| Apr 3, 2025 | 2.26 | -0.01 | -0.44% | 2.27 | 2.36 | 2.23 |
| Apr 2, 2025 | 2.45 | 0.11 | 4.70% | 2.34 | 2.51 | 2.33 |
| Apr 1, 2025 | 2.44 | -0.06 | -2.40% | 2.50 | 2.51 | 2.34 |
| Mar 31, 2025 | 2.58 | 0.00 | 0.00% | 2.58 | 2.67 | 2.42 |
| Mar 28, 2025 | 2.68 | -0.21 | -7.27% | 2.89 | 2.93 | 2.66 |
| Mar 27, 2025 | 2.96 | 0.19 | 6.86% | 2.77 | 3.04 | 2.77 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Relay Therapeutics, Inc. Company profile
About Relay Therapeutics Inc
Relay Therapeutics Inc. is a clinical-stage precision medicines company. The Company is focused on transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. The Company is advancing a pipeline of medicines to address targets in precision oncology, including its lead product candidates, RLY-4008, RLY-2608 and RLY-1971. Its RLY-1971 binds and stabilizes Src homology region two (SH2)-containing protein tyrosine phosphatase two (SHP2) in its inactive conformation. Its RLY-4008, is it inhibitor of fibroblast growth factor receptor 2 (FGFR2), enriched for patients with advanced solid tumors having oncogenic FGFR2. The Company uses its Dynamo platform to focus on precision oncology. It is also advancing several early programs focused on other precision oncology and genetic disease targets.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Relay Therapeutics Inc revenues decreased 96% to $3M. Net loss applicable to common stockholders increased 58% to $363.9M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects General and ad increase of 60% to $33M (expense), Stock-based Compensation in R&D increase of 70% to $24.9M (expense).
| Industry: | Biotechnology & Medical Research (NEC) |
399 Binney Street
2nd Floor
CAMBRIDGE
MASSACHUSETTS 02139
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com